Search
for
Sort by
Research 301–330 of 1000+
- Hair Follicle-Targeted Delivery of Azelaic Acid Micro/Nanocrystals Promote the Treatment of Acne Vulgaris
- Research Progress on Targeted Regulation of Hair Follicle Stem Cell Function in the Treatment of Androgenetic Alopecia
- Management of the adverse effects of targeted therapy for cancer
- Design of a targeted drug delivery system to reshape the perifollicular microenvironment in androgenetic alopecia
- 032 A multicomponent skin-targeted COVID-19 vaccine elicits robust humoral and cellular immune responses
- Folate-cyclodextrin Conjugate for Targeted Chemotherapy
- Faculty Opinions recommendation of Targeted skin overexpression of the mineralocorticoid receptor in mice causes epidermal atrophy, premature skin barrier formation, eye abnormalities, and alopecia.
- Colon Cancer Stem Cells: Promise of Targeted Therapy
- Defective trophoblast function in mice with a targeted mutation of Ets2
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted <sup>99m</sup>Tc-Radioimaging Agents
- Characterization of Hair Follicle Antigens Targeted by the Anti-Hair Follicle Immune Response
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- Self-assembled polymeric nanocarriers for the targeted delivery of retinoic acid to the hair follicle
- Cellular senescence in skin‐related research: Targeted signaling pathways and naturally occurring therapeutic agents
- Uterus Hyperplasia and Increased Carcinogen-Induced Tumorigenesis in Mice Carrying a Targeted Mutation of the Chk2 Phosphorylation Site in Brca1
- Microneedles mediated bioinspired lipid nanocarriers for targeted treatment of alopecia
- Non-Rash Skin Toxicities Associated with Novel Targeted Therapies
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Degradable co-delivery nanoplatforms for inflammation-targeted therapy against atherosclerosis
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Current and prospective strategies for advancing the targeted delivery of CRISPR/Cas system via extracellular vesicles
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases
- Basal Cell Carcinoma, Hedgehog Signaling, and Targeted Therapeutics: The Long and Winding Road
- Catamenial-like seizure exacerbation in mice with targeted ablation of extrasynaptic δGABA-a receptors in the brain
- Platelet-rich plasma as a site-targeted approach in wound healing: a molecular perspective
- Methodologies to Evaluate the Hair Follicle-Targeted Drug Delivery Provided by Nanoparticles
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Safety and efficacy of advanced and targeted acid α-glucosidase (AT-GAA) (ATB200/AT2221) in ERT-switch nonambulatory patients with Pompe disease: preliminary results from the ATB200-02 trial